Drug Development Research

Cover image for Drug Development Research

1988

Volume 14, Issue 3-4

Pages fmi–fmi, 181–384

  1. Masthead

    1. Top of page
    2. Masthead
    3. Miscellaneous
    4. Articles
    1. Masthead (page fmi)

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140301

  2. Miscellaneous

    1. Top of page
    2. Masthead
    3. Miscellaneous
    4. Articles
    1. You have free access to this content
      New drug strategies in the treatment of senile dementia of different origin (page 181)

      Kevin L. Keim and Béla Kiss

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140302

  3. Articles

    1. Top of page
    2. Masthead
    3. Miscellaneous
    4. Articles
    1. Ten years of experience with cavinton (pages 185–187)

      E. Csanda, P. Harcos, Z. Bácsy, R. Berghammer and J. Kenéz

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140304

    2. Drug treatment of alzheimer's disease (page 189)

      Leon J. Thal

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140305

    3. Possible memory-enhancing properties of vinpocetine (pages 191–193)

      Donna M. Coleston and Ian Hindmarch

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140306

    4. Efficacy of denbufylline in patients with multi-infarct dementia (pages 195–198)

      M. O'Connolly, D. Dierdorf, Dr. W. H. Greb, M.-E. R. Mayer and D. Wolf

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140307

    5. Restoration of microsieve filterability of human red cells after exposure to hyperosmolarity and lactacidosis: Effect of vinpocetine (pages 205–211)

      H. Schmid-Schönbein, R. Grebe, P. Teitel, G. Artmann, H. Eschweiler and Susanne Schröder

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140309

    6. Multicenter clinical placebo-controlled study with acetyl-l-carnitine (LAC) in the treatment of mildly demented elderly patients (pages 213–216)

      Dr. Domenico Cucinotta, Mario Passeri, Sandro Ventura, Maurizio Lannuccelli, Umberto Senin, Piero Angelo Bonati and Lucilla Parnetti

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140310

    7. A double-blind, placebo-controlled study with oxiracetam in demented patients administered the Luria-Nebraska Neuropsychological Battery (pages 217–222)

      A. Mangoni, C. Perin, S. Smirne, I. Piccolo, F. De Filippi, C. Marchetti, A. Motta and G. C. Monza

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140311

    8. Pharmacologic corrections of cerebral blood flow and CO2-reactivity in cerebrovascular insufficiency (pages 223–225)

      G. B. Weinstein, V. E. Parfenov, M. Bodo and B. V. Gaidar

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140312

    9. Computed tomography study of cerebral infarctions treated with vinpocetine (pages 227–230)

      Pavel Kalvach, Jiří Bauer and Josef Vymazal Jr.

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140313

    10. Correlations between memory, language, gnosia, and praxia in 80 patients with senile dementia of the alzheimer type (pages 231–234)

      Dr. M. Roudier, P. Marcie, N. Podrabinek, Y. Lamour and P. Davous

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140314

    11. Strategies and new aspects in the pharmacology of drugs for the treatment of senile dementia (pages 251–262)

      Prof. Dr. Joachim Schmidt, Hans-Dieter Fischer and Christian Wustmann

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140317

    12. Effect of vinpocetine on monoamine receptor binding and synaptosomal uptake in the rat brain (pages 281–283)

      Dr. David K. H. Lee and G. Geiger

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140319

    13. Vinpocetine facilitates noradrenaline release in rat brain cortex slices (pages 285–291)

      Dr. E. Schlicker, R. Betz and M. Göthert

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140320

    14. Effect of nootropic drugs on age-dependent changes in transmitter release (pages 293–295)

      Omr Prof. Dr. sc. med. Joachim Schmidt, Christian Wustmann, Erika Rudolph, Eva-Maria Zschorn and Hans-Dieter Fischer

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140321

    15. Calcium antagonist activity of vinpocetine and vincamine in several models of cerebral ischaemia (pages 297–304)

      Jean-Claude Lamar, Hervé Poignet, Michèle Beaughard and Georges Dureng

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140322

    16. Hoe 288: Indications on the memory-enhancing effects of a peptidase inhibitor (pages 315–324)

      Dr. Patricia Usinger, Franz J. Hock, Gabriele Wiemer, Hermann J. Gerhards, Rainer Henning and Hansjörg Urbach

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140324

    17. Effect of vinpocetine on age-related differences in brain function of aged fischer rats (pages 325–333)

      Ronald R. Notvest, Tracey A. Emrey and John J. Inserra

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140325

    18. Effect of vinpocetine on the sleep-wake cycle of rats (pages 335–341)

      Adam Sarkadi, Judit Laszy and Lászlö Szporny

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140326

    19. Variation of muscarinic activities of oxotremorine analogues (pages 343–347)

      Dr. Frank Brown, Michael Clark, Diane Graves, Michael Hadley, John Hatcher, Robert McArthur, Graham Riley and James Semple

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140327

    20. Effect of denbufylline in passive avoidance trials in gerbils, following transiet forebrain ischaemia, and in mice (pages 349–352)

      C. D. Nicholson, J. J. Jukna, R. Wilke and Dr. D. Angersbach

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140328

    21. Experimentally established geropsychotropic properties of 3-hydroxypyridine antioxidant (pages 353–358)

      Dr. T. A. Voronina and O. A. Kutepova

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140329

    22. Animal models for evaluation of age-related changes in behaviour (pages 363–368)

      Dr. Gert Schulze, Helmut Coper and Bernhard Jänicke

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140331

    23. Influence of nootropic drugs on the stimulus-release relationship of dopaminergic structures (pages 369–372)

      Dr. Christian Wustmann, Hans-Dieter Fischer, Erika Rudolph and Joachim Schmidt

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140332

    24. Beneficial effects of idebenone on memory impairment in rats (pages 373–384)

      Dr. A. Nagaoka, Y. Nagai, N. Yamazaki, M. Miyamoto and Y. Kiyota

      Article first published online: 5 OCT 2004 | DOI: 10.1002/ddr.430140333

SEARCH

SEARCH BY CITATION